Comorbidity as a predictor of stage of illness for patients with breast cancer

Medical Care

Volumn 43, Issue 2, 2005, Pages 132-140

  Fleming, Steven T ^a   Pursley, Holly G ^b   Newman, Beth ^c   Pavlov, Dmitri ^a,d   Chen, Kun ^a,e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d PFIZER INC   (United States)

^e BAYER CORPORATION   (United States)

Author keywords

Breast cancer; Claims data; Comorbidity; Medicare; Stage of illness

Indexed keywords

AGED; ARTICLE; BLOOD DISEASE; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER STAGING; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; COMORBIDITY; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MEDICARE; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; RISK ASSESSMENT;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; DIGESTIVE SYSTEM DISEASES; FEMALE; HEMATOLOGIC DISEASES; HUMANS; HYPERTENSION; KIDNEY DISEASES; MENTAL DISORDERS; MUSCULOSKELETAL DISEASES; NEOPLASM STAGING; PROGNOSIS; UNITED STATES;

EID: 13544259583     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200502000-00006     Document Type: Article

References (36)

1. Ries LAG, Eisner MP, Kosary CL, et al, eds. SEER Cancer Statistics Review, 1975-2000, Bethesda, MD: National Cancer Institute; 2003; available at http://seer.cancer.gov/csr/1975_2000. Accessed November 17, 2004.
2. Adami H, Hunter D, Trichopoulos D. Textbook of Cancer Epidemiology. New York: Oxford University Press; 2002.
3. Potosky AL, Riley GF, Lubitz JD, et al. Potential for cancer-related health services research using a linked Medicare tumor registry database. Med Care. 1993;31:732.
4. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003; 163:49-56.
5. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994; 120:104-110.
6. Newschaffer CJ, Bush TL, Penberthy LE, et al. Does comorbid illness interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol Med Sci. 1998;53A:M372-M378.
7. Yancik R, Wesley MN, Ries LAG, et al. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285:885-892.
8. Vaeth PA, Satariano WA, Ragland DR. Limiting comorbid conditions and breast cancer stage at diagnosis. J Gerontol A Biol Sci Med Sci. 2000;55:M593-600.
9. West DW, Satariano WA, Ragland DR, et al. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol. 1996;6:413-419.
10. Vaeth PA, Satariano WA. Alcohol consumption and breast cancer stage at diagnosis. Alcoholism.. 1998;22:928-934.
11. Desai MM, Bruce ML, Kasl SV. The effects of major depression and phobia on stage at diagnosis of breast cancer. Int J Psychiatry Med. 1999;29:29-45.
12. Kiefe CI, Funkhouser E, Fouad MN, et al. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med. 1998;13:357-365.
13. Bostick RM, Sprafka JM, Virnig BA, et al. Predictors of cancer prevention attitudes and participation in cancer screening examinations. Prev Med. 1994;23:816-826.
14. Grady KE, Lemkau JP, McVay JM, et al. The importance of physician encouragement in breast cancer screening of older women. Prev Med. 1992;21:766-780.
15. Burack RC, Liang J. The acceptance and completion of mammography by older black women. Am J Public Health. 1989;79:721-726.
16. Schoen RE, Marcus M, Braham RL. Factors associated with the use of screening mammography in a primary care setting. J Community Health. 1994;19:239-252.
17. Schapira MM, McAuliffe TL, Nattinger AB. Underutilization of mammography in older breast cancer survivors. Medical Care. 2000;38:281-288.
18. Satariano WA. Comorbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis. J Gerontol. 1992;47(Spec No):24-31.
19. Fleming ST, Dmitrienko A, Rastogi A. A comprehensive prognostic Index to predict mortality based on multiple comorbidities: a focus on breast cancer. Medical Care. 1999;37:601-614.
20. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
21. Health Resources and Services Administration, Bureau of Health Professions, Area Resource File (ARF) System. Fairfax, VA: Quality Resource Systems, Inc.; Feb 1997.
22. Makuc DM, Hagland B, Ingram DD, et al. Vital and Health Statistics - Health Service Areas for the United States. Hyattsville, MD: National Center for Health Statistics; 1991.
23. Randolph Mahnken JD, Goodwin JS, et al. Using Medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different definitions to identify screening mammograms. Health Serv Res. 2002;37:1643-1657.
24. Khuder SA, Mutgi AB. Breast cancer and NSAID use: a meta-analysis. Br J Cancer. 2001;84:1188-1192.
25. Jaen CR, Strange KC, Nutting PA. Competing demands of primary care: a model for the delivery of clinical preventive services. J Family Practice. 1994;38:166-171.
26. Marwill SL, Freund KM, Barry PP. Patient factors associated with breast cancer screening among older women. J Am Geriatr Soc. 1996;44: 1210-1214.
27. Berrino F, Bellati C, Secreto G, et al. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev. 2001;10:25-33.
28. Stoll BA. Adiposity as a risk determinant for postmenopausal breast cancer. Int J Obes Relat Metab Disord. 2000;24:527-33.
29. Stoll BA. Biological mechanisms in breast cancer invasiveness: relevance to preventive interventions. Eur J Cancer Prev. 2000;9:73-9.
30. Yang G, Lu G, Jin F, et al. Population-based, case-control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10:1207-1211.
31. Kaaks R. Plasma insulin, IGF-I and breast cancer. Gynecol Obstet Fertil. 2001;29:185-91.
32. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998;351:1393-1396.
33. Unterburger P, Sinop A, Noder W, et al. Diabetes mellitus and breast cancer. A retrospective follow-up study. Onkologie. 1990;13:17-20.
34. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
35. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Medical Care. 1994;32:81-90.
36. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53: 1258-1267.